É sabido que: (i) as sínteses individual e múltipla (manual e automática), bem como a construção de bibliotecas e micro-arranjos de peptídeos sintéticos empregam a metodologia da fase sólida (SPFS); (ii) apesar do desenvolvimento atual desta metodologia sintética, os químicos de peptídeos continuam se deparando com problemas e limitações inerentes a ela; (iii) muitos trabalhos relatam a sua agilização pelo uso de altas temperaturas, mas poucos revelam preocupação com a integridade quiral dos peptídeos-alvo. Portanto, o presente trabalho objetivou dar continuidade à nossa investigação pioneira das: 1) incidência da enantiomerização dos aminoácidos e/ou de outras reações secundárias nas SPFS passo a passo de peptídeos a 60 °C; 2) viabilidade de realização de todas as etapas da síntese convergente em fase sólida (SCPFS) a 60 °C. Em relação ao tópico 1, os peptídeos-alvo escolhidos tinham tamanho e sequência variáveis que incluiam os aminoácidos trifuncionais problemáticos Cys, Ser, His, Met e Trp. Todos eles foram obtidos por SPFS passo a passo convencional e a 60 °C usando aquecimento convencional e micro-ondas. A identificação e a quantificação dos isômeros contaminantes foram feitas com a ajuda de padrões resultantes da SPFS passo a passo convencional e de métodos analíticos (RP-HPLC, LC-ESI/MS, CE e análise quiral de aminoácidos) em condições estabelecidas por nós. Foi constatado que: (i) as nossas condições de acoplamento são mais econômicas que as usuais, pois empregam menor concentração e excesso molar de N-acil-aminoácidos; (ii) nelas, a SPFS a 60 °C usando o aquecimento convencional é simples, prática, de custo relativamente baixo, demanda ½ do tempo da SPFS convenciona e não compromete significativamente a integridade quiral dos aminoácidos; (iii) nas condições similares, a SPFS passo a passo a 60 °C assistida por micro-ondas é mais rápida (realizada em ¼ do tempo gasto na SPFS convencional), porém mais cara e acompanhada de aumento significativo da enantiomerização da Cys; (iv) a mistura 25% DMSO/tolueno, nunca antes utilizada na SPFS assistida por micro-ondas, favoreceu a formação de contaminantes contendo Met oxidadas a sulfóxidos durante as sínteses do fragmento CCK24-33NS, mas o mesmo ocorreu quando DMF foi usado nas sínteses da CCK-33 NS; (v) outras reações secundárias típicas da SPFS passo a passo não foram intensificadas significativamente nas nossas condições sintéticas a 60 °C. Quanto ao tópico 2, foi escolhida a CCK-33 NS como modelo peptídico. Foi constatado que: (i) a etapa de obtenção dos fragmentos peptídicos protegidos que atuariam como doadores de acila (D.A.) e aceptor de acila (A.A.) de partida pode ser ágil e bem sucedida pela SPFS passo a passo a 60 °C nas nossas condições experimentais usando o aquecimento convencional; (ii) DMF, NMP e 25% DMSO/Tolueno foram adequados à solubilização dos fragmentos D.A. e dos reagentes necessários à sua ativação a 60 °C; (iii) a 60 °C, tais solventes também intumesceram satisfatoriamente a CCK24-33NS-resina Rink amida, A.A. de partica; (iv) o aquecimento convencional permitiu que algumas reações de acoplamento entre os D.A. e A.A. escolhidos fossem realizadas com sucesso; na maioria dos casos em que isso não ocorreu, o uso combinado das micro-ondas e agitação sob atmosfera inerte mediaram a formação do produto desejado; (v) a natureza dos fragmentos D.A. e A.A. é fator limitante na SCPFS, mesmo a 60 °C e usando o aquecimento convencional ou as micro-ondas, e, portanto, ele precisa ser melhor estudado. / It is well known that: (i) individual and multiple peptide syntheses (manual and automatic) as well as construction of synthetic peptide libraries and micro-arrays are all based on solid phase chemistry (SPPS); (ii) despite the current development of such synthetic methodology, peptide chemists are still facing its problems and inherent limitations; (iii) many previous works employed high temperatures to accelerate stepwise SPPS, but only a few showed concern about the preservation of the chiral integrity of the target peptide. Therefore, the main goal of the present work was to continue our pioneering investigation of: 1) the incidence of amino acids enantiomerization and/or other side-reactions in the stepwise SPPS at 60°C, 2) the viability of performing all steps of the convergent synthesis on a solid support (CSPPS) at 60°C. With regard to the topic 1, the peptides chosen as targets had variable size and sequence, which included the tricky trifunctional amino acids Cys, Ser, His, Met and Trp. The peptides were synthesized by conventional stepwise SPFS and at 60 °C using conventional or microwave heating. Identification and quantification of the contaminant isomers was done with the aid of standards resultant from conventional stepwise SPPS and of analytical methods (RP-HPLC, LC-ESI/MS, CE and chiral amino acids analysis) in conditions established in our laboratory. It was shown that: (i) our coupling conditions are cheaper than the usual ones as they employ lower concentration and excess of N-acyl-amino acids; (ii) under them, stepwise SPPS at 60 °C using the conventional heating is simple, practical, relatively low-cost, demands half of the time required by conventional stepwise SPPS and does not cause the enhancement of amino acids enantiomerization; (iii) under similar conditions, microwave-assisted stepwise SPPS at 60 °C is faster (it demands only one-fourth of the time spent in the conventional stepwise SPPS), but it is more expensive and causes significant damage specially to the chiral integrity of Cys; (iv) the binary mixture 25% DMSO/toluene, never used earlier in microwave-assisted stepwise SPPS, led to the formation of contaminants with Met oxidized to its sulfoxides during the synthesis of CCK24-33NS; however, it also occurred when DMF was used in the synthesis of CCK-33 NS; (v) other side reactions typical of stepwise SPPS were not significantly intensified under our conditions at 60 °C. Concerning to the topic 2, CCK-33 NS was chosen as the model peptide. It was shown that: (i) the synthesis of the protected peptides that would act as acyl donor (A.D.) or as the starting acyl aceptor (A.A.) can be fast and successfully achieved at 60 °C under our experimental conditions using conventional heating; (ii) DMF, NMP and 25% DMSO/toluene dissolved all A.D. and the reagents required for their activation at 60 °C; (iii) at this temperature, such solvents were also able to properly swell CCK24-33NS-Rink amide resin, the starting A.A.; (iv) the conventional heating allowed for some coupling reactions between A.D. and A.A., but in most cases in which it did not occur, the combined use of microwaves and stirring under inert atmosphere mediated the formation of the desired products; (v) the nature of fragments A.D. and A.A. is a limiting factor in the CSPPS even at 60 °C and using the conventional or microwave heating; therefore, it should be further studied.

<p> </p> <p>Infectious diseases caused by bacteria, fungi, and plasmodium parasites are a huge global health problem which ultimately leads to millions of deaths annually. The emergence of strains that exhibit resistance to nearly every class of antimicrobial agents, and the inability to keep up with these resistance trends has brought to the fore the need for new therapeutic agents (antibacterial, antifungal, and antimalarial) with novel scaffolds and functionalities capable of targeting microbial resistance. A novel class of compounds featuring an aryl isonitrile moiety has been discovered that exhibits potent inhibitory activity against several clinically relevant strains of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). Synthesis, structure-activity relationship (SAR) studies, and biological investigations have led to lead molecules that exhibit anti-MRSA inhibitory activity as low as 1 – 2 µM. The most potent compounds have also been shown to have low toxicity against mammalian cells and exhibit <i>in vivo</i> efficacy in MRSA skin and thigh infection mouse models.</p> <p>The novel aryl isonitriles have also been evaluated for antifungal activity. This study examines the SAR of aryl isonitrile compounds and showed the isonitriles as compounds that exhibit broad spectrum antifungal activity against species of <i>Candida</i> and <i>Cryptococcus</i>. The most potent derivatives are capable of inhibiting growth of these pathogens at concentrations as low as 0.5 µM. Notably, the most active compounds exhibit excellent safety profile and are non-toxic to mammalian cells up to 256 µM.</p> <p>Beyond the antibacterial and antifungal activities, structure-antimalarial relationship analysis of over 40 novel aryl isonitrile compounds has established the importance of the isonitrile functionality as an important moiety for antimalarial activity. Of the many isonitrile compounds exhibiting potent antimalarial activity, two have emerged as leads with activity comparable to that of Artemisinin. The SAR details presented in this study will prove essential for the development new aryl isonitrile analogues to advance them to the next step in the antimalarial drug discovery process.</p> <p>17-nor-Excelsinidine, a zwitterion monoterpene indole alkaloid isolated from <i>Alstonia scholaris</i> is a subject of synthetic scrutiny. This is primarily due to its intriguing chemical structure which includes a bridged bicyclic ammonium moiety, and its anti-adenovirus and anti-HSV activity. Herein we describe a six-step total synthesis of (±)-17-nor-Excelsinidine from tryptamine. Key to the success of this synthesis is the use of palladium-catalyzed carbonylative heck lactamization methodology which built the 6, 7-membered ring lactam in one step. The resulting pentacyclic product, beyond facilitating the easy access to (±)-17-nor-Excelsinidine, could also serve as a precursor to other related indole alkaloids.</p> <br> <p> </p> <p></p>

<div>Enantioselective syntheses of hexacyclic aspidoalbidine alkaloids (+)-fendleridine and (+)-acetylaspidoalbidine are described. These syntheses feature an asymmetric decarboxylative allylation and photocyclization of a highly substituted enaminone. Also, the synthesis highlights the formation of a C19-hemiaminal ether via a reduction/condensation/intramolecular cyclization cascade with the C21-alcohol. The present synthesis provides convenient access to the aspidoalbidine hexacyclic alkaloid family in an efficient manner.</div><div>A copper-catalyzed cross-coupling is described. Use of Cu(I) salts in the presence of allyl bromides and organostannyl furans were found to undergo catalytic turnover under ambient conditions and afford the coupled products in good to great yields. Model substrate screening led to conditions used in the concise formal synthesis of FR901464 analogues. Optimization of the described coupling step led to suppression of undesired isomers and byproducts affording the desired diene coupled product in high yield, stereo-, and regioselectivity on a multigram scale. Novel protection of the resulting diene moiety as an unconventional protecting group, and a facile four-step single column chromatographic stereoselective sequence are also reported.</div>

According to the International Diabetes Federation (IDF), there were 371 million people in the age from 20 to 79 years worldwide affected by diabetes in 2012. This means diabetes has become a global epidemic disease and, therefore, the importace of insulin research still grows. Insulin is a protein hormone that plays a key role in regulating blood glucose level which has a widespread impact on whole metabolism. Insulin acts through binding of its monomeric form to the insulin receptor. It is clear that insulin monomer has to undergo structural changes upon binding to the insulin receptor as the residues which are crucial for the interaction are burried within the native form. According to studies of highly active hormone analogs and the new information about the insulin-insulin receptor complex, there is a strong evidence that the C-terminal part of the B-chain is a dynamic element in insulin activation and receptor binding. Probably, there is also a great importance of the B-chain N- terminus and the transition between T and R conformations of insulin. However, the exact significance of the T and R states of insulin still remains unclear. In this work, several new insulin analogs AibB3-insulin, AibB5-insulin, AibB8- insulin, N-MeAlaB8-insulin and D-ProB8-insulin were prepared for the purpose of...

L’objectif de ce travail est de remplacer les catalyseurs organométalliques à base d’étain et de mercure utilisés lors de la synthèse de polyuréthane via la réaction isocyanate – alcool. Une étude bibliographique a montré que la basicité et la nucléophilie d’un catalyseur organique gouvernent son activité et le mécanisme réactionnel qu’il induit. Pour les catalyseurs organométalliques, ces propriétés catalytiques s’expliquent par des considérations électroniques ainsi que par le principe HSAB. D’autre part, une étude approfondie du catalyseur organomercuriel a été menée. Elle a révélé l’intérêt d’ajouter à l’espèce catalytique organométallique un acide carboxylique, de préférence à longue chaîne carbonée. Celui-ci ralentit l’hydrolyse du catalyseur tout en augmentant sa sélectivité envers la réaction isocyanate – alcool. De nouveaux catalyseurs ou systèmes catalytiques originaux ont ensuite été évalués grâce à un test simplifié. Trois catalyseurs organométalliques ont ainsi été sélectionnés pour de nouveaux essais dans des conditions plus proches de celles rencontrées dans l’industrie. Ils se sont tous révélés actifs, mais seul le -dicétonate de zinc II permet d’obtenir un prépolymère incolore et transparent, deux critères essentiels pour les applications visées. Il pourrait donc remplacer le catalyseur organostannique. Enfin, l’étude de la sélectivité de systèmes catalytiques impliquant un catalyseur commercial en présence d’acide néodécanoïque a confirmé le rôle protecteur de ce dernier. La sélectivité du complexe de zinc retenu précédemment a par ailleurs été évaluée et apparaît 2,5 fois supérieure à celle du complexe organomercuriel à remplacer. / The aim of this work is to replace organotin and organomercury catalysts used for the synthesis of polyurethane via the isocyanate – alcohol reaction. A bibliographic review revealed that basicity and nucleophilicity of an organic catalyst affect its activity and the reaction mechanism it induces. For organometallic catalysts, these catalytic properties can be explained by electronic considerations and by the HSAB principle. On the other hand, a comprehensive study of the organomercury catalyst highlighted the benefit to combine it with a carboxylic acid, preferably with a long carbon backbone. This slows down hydrolysis of the catalyst while increasing its selectivity toward the isocyanate – alcohol reaction. New original catalysts or catalytic systems were then evaluated using a simplified experiment. Three organometallic catalysts were selected for further testing in conditions closer to industrial ones. They all showed appropriate catalytic activity, but the zinc II -diketonate is the only one to provide a colorless and transparent prepolymer, two essential criteria for the intended applications. This complex could therefore replace the organotin catalyst. Finally, the study of the selectivity of catalytic systems involving a commercial catalyst in the presence of neodecanoic acid confirmed its protective role toward hydrolysis. The previously retained zinc complex was also evaluated and revealed a selectivity 2.5 times greater than that of the organomercurial complex to replace.

The misassembly of soluble proteins into toxic aggregates, including amyloid fibrils, underlies a large number of human degenerative diseases. Cardiac amyloidoses, which are most commonly caused by aggregation of Immunoglobulin (Ig) light chains or transthyretin (TTR) in the cardiac interstitium and conducting system, represent an important and often underdiagnosed cause of heart failure. Two types of TTR-associated amyloid cardiomyopathies are clinically important. The Val122Ile (V122I) mutation, which alters the kinetic stability of TTR and affects 3% to 4% of African Americans, can lead to development of familial amyloid cardiomyopathy. In addition, aggregation of WT TTR in individuals older than age 65 years causes senile systemic amyloidosis. TTR-mediated amyloid cardiomyopathies are chronic and progressive conditions that lead to arrhythmias, biventricular heart failure, and death. As no Food and Drug Administration-approved drugs are currently available for treatment of these diseases, the development of therapeutic agents that prevent TTR-mediated cardiotoxicity is desired. Here, we report the characterization of AG10 , a potent and selective kinetic stabilizer of TTR. AG10 prevents dissociation of V122I-TTR in serum samples obtained from patients with familial amyloid cardiomyopathy. In contrast to other TTR stabilizers currently in clinical trials, AG10 stabilizes V122I- and WT-TTR equally well and also exceeds their efficacy to stabilize WT and mutant TTR in whole serum. Crystallographic studies of AG10 bound to V122I-TTR give valuable insights into how AG10 achieves such effective kinetic stabilization of TTR, which will also aid in designing better TTR stabilizers. The oral bioavailability of AG10 , combined with additional desirable drug-like features, makes it a very promising candidate to treat TTR amyloid cardiomyopathy. The second part of the thesis discusses harnessing TTR as a platform to enhance in vivo half-life of therapeutic peptides. The tremendous therapeutic potential of peptides has not yet been realized, mainly owing to their short in vivo half-life. Although conjugation to macromolecules has been a mainstay approach for enhancing protein half-life, the steric hindrance of macromolecules often harms the binding of peptides to target receptors, compromising the in vivo efficacy. Here we report a new strategy for enhancing the in vivo half-life of a model peptide Gonadotropin Releasing Hormone (GnRH) and its analog GnRH-A without compromising their potency. Apart from GnRH, we have used other peptides to study their proteolytic stability in vitro . Our approach involves endowing peptides with a small molecule that binds reversibly to the serum protein transthyretin. Although there are a few molecules that bind albumin reversibly, we are unaware of designed small molecules that reversibly bind other serum proteins and are used for half-life extension in vivo . We show here that our strategy was effective in enhancing the half-life of an agonist for GnRH receptor while maintaining its binding affinity, which was translated into superior in vivo efficacy.

<p>Extracellular matrix (ECM) creates high-resolution chemical patterns, by assembling simple molecules with nm-scale features (e.g., carbohydrates, nucleotides, amino acids) into complex structures up to micrometers and extending to even larger scales across tissues (e.g., glycans, DNA, proteins), capable of carrying out the diverse and complex cellular functions. Mimicking the complexity of such biological systems requires precise control over the chemical patterning on substrates that exhibit physiochemical properties similar to biological systems (such as hydrogels). Although hydrogels provide tunable physiochemical properties suitable for biological applications; it is a porous material where pore sizes can range from 30 nm to greater than 1000 nm. Due to this structural heterogeneity, chemical patterning below the length scale of this heterogeneity is very challenging.</p> <p>Here, we demonstrate a new assembly system for generating a nanostructured presentation of carbohydrates on the hydrogel surface. This approach is based on the striped phases assembly of functional alkanes where 1-nm resolution functional patterns are readily assembled on substrates such as highly ordered pyrolytic graphite (HOPG). In this assembly, molecules are stabilized by noncovalent interactions, including alkyl-pi interactions underlying the HOPG, van der Waals interaction between the adjacent alkyl chains, and hydrogen bonding between polar head groups. Topochemical polymerization converts internal diynes into conjugated polydiacetylenes (PDAs). PDAs can also be utilized to covalently attach the striped pattern to polyacrylamide hydrogels through free radical chemistry.</p> <p>Here, we synthesize new amphiphiles with carbohydrate headgroups (N-acetyl-D-glucosamine (GlcNAc), and D-glucuronic acid (GlcA)), assembled into striped phases on HOPG and covalently transfer to polyacrylamide hydrogels. GlcNAc binds to wheat germ agglutinin (WGA), a lectin that binds specifically in a multivalent fashion (dissociation constant KD in nm range) to GlcNAc. We show that GlcNAc striped phases generate highly selective interactions with wheat germ agglutinin (WGA) but do not induce specific binding with concanavalin A (another lectin molecule that does not target GlcNAc). We further demonstrate that WGA binding affinity can be modulated by shifting the position of diacetylenes that bring the polymer backbone closer to the GlcNAc, increasing the effecting local concentration of carbohydrates.</p> <p>We investigated the possibility of using sPDA for secondary functionalization with complex biological molecules (such as biotin and cRGD) to mimic the ECM composition closely. The unusual reactivity of the sPDA backbones during the covalent transfer of the striped phase monolayer to hydrogels illustrates the potential of sPDA reactivity azides. In this work, we show that the addition of substituted azide molecules to sPDA-functionalized hydrogels produces a decrease in the fluorescence of the sPDA monolayer. Since these reactions are occurring on porous hydrogel surfaces characterization using techniques such as IR or NMR is difficult. We carried out further solution-phase reactions using a soluble PDA where PDA UV-vis absorption spectra red-shift after the reaction between the PDA backbone and azide. These experiments support the hypothesis of sPDA and azide click reaction.</p>

For any drug candidate to be approved by the U.S. Food and Drug Administration, it must meet strict standards for safety and efficacy. While the field of nuclear medicine is over 100 years old, traditional methods such as external beams or systematic administration have rarely met these standards or have limited application. Ligand-targeted therapy and diagnostics, or “theranostics,” has emerged in the past several decades as an exciting field that offers new possibilities to design drugs that are both safe and effective. When applied to nuclear medicine, the field of ligand-targeted radioactive theranostics is younger still, with many critical lessons being discovered and applied currently. This dissertation outlines the necessary principles of radioactive theranostic drug design, then demonstrates the application of several more recent techniques to improve both the efficacy and safety of radioactive theranostics targeting two high priority oncological targets: fibroblast activation protein alpha and folate receptor.

Объект изучения – модуль плазмохимического травления и осаждения на базе нанотехнологического комплекса Нанофаб-100. Цель работы — плазмохимический синтез тонких покрытий на основе нитридов алюминия и титана. Методы исследования: плазмостимулированное химическое осаждение из газовой фазы, электрохимическое окисление, плазменное азотирование, сканирующая электронная и атомно-силовая микроскопия, оптическая спектроскопия, наноиндентирование. В результате исследования разработана методика синтеза нитрида алюминия на установке плазмохимического синтеза. Синтезированы тонкие пленки нитрида алюминия толщиной 50-200 нм. Продемонстрирована возможность получения наноточек нитрида алюминия. С помощью плазмохимического азотирования модифицирована поверхность металлического титана с увеличением твердости в 4 раза. Показана возможность получения нанотубулярных структур нитрида титана, являющихся перспективными в целях создания электронных устройств, фотокаталитических ячеек и др. Результаты работы отражены в тезисах докладов III Международной молодежной научной конференции «Физика. Технологии. Инновации. ФТИ-2016». / The object of this study is the module of plasma chemical etching and deposition based on nanotechnology complex Nanofab-100. The goal of the current paper is the plasma-chemical synthesis of thin coatings based on aluminum and titanium nitrides. As a result of the research, a technological map for the routine of the plasma-chemical synthesis and a technique for obtaining nanomaterials on the example of aluminum nitride have been developed. There were synthesized thin films of aluminum nitride with 50-200 nm thickness. The possibility of synthesis nano-dots of AlN is demonstrated. The surface of metallic titanium has been modified with an increase in hardness by 4 times using plasma-assisted nitriding process. The possibility of obtaining nanotubular structures of titanium nitride, which are promising for microelectronic and photocatalysis, is shown. The results of the work are reported in abstracts of the III International Youth Scientific Conference «Physics. Technologies. Innovation. FTI-2016».

No / Novel 1- and 1,4-substituted chloroethylaminoanthraquinones with DNA binding and alkylating properties along with their respective hydroxyethylaminoanthraquinone intermediates were synthesized. Selected chloroethylaminoanthraquinones were shown to cross-link DNA and alkylate guanines (at low nM concentration) with a preference for reaction sites containing 5'-PyG. A compound (Alchemix) with the bis-chloroethyl functionality confined to one side chain alkylated but did not cross-link DNA. All the 1,4-disubstituted chloroethylaminoanthraquinones were potently cytotoxic (nM IC50s) against cisplatin-resistant ovarian cancer cell lines.